Keith Speights

Key Points No one knows for sure if a stock market crash is on the way -- even Buffett. However, the legendary investor's playbook includes a simple step to be ready just in case.

The stock market is making history, but not necessarily in a good way.

Griffin's Q2 move is already paying off nicely. It's easy for a stock to get lost in the crowd when a portfolio has an enormous number of holdings.

Key Points Griffin's Citadel hedge fund nearly quadrupled its stake in Eli Lilly in Q2. Lilly's diabetes and obesity drugs continue to enjoy impressive momentum.

Key Points The S&P 500 Shiller CAPE ratio has topped 40 only once before. When this valuation metric has spiked in the past, it has led to stock market sell-offs.

Great expectations surround Nvidia's fiscal 2027 Q2 update this week. Every quarter, the most highly anticipated earnings report is announced.

Key Points Nvidia is expected to report strong growth in its upcoming Q2 update. However, its stock has often fallen after beating Wall Street earnings estimates.

One of the most successful investors ever really likes this up-and-coming biotech stock.

Key Points Druckenmiller added roughly 26.5% to his position in Revolution Medicines in Q2.

This biotech leader continues to rack up clinical successes. Argenx ARGX already markets Vyvgart Hytrulo for treating generalized myasthenia